https://finance.yahoo.com/news/novo-nordisk-1-3-billion-111211696.html
Novo Nordisk has agreed to buy ocedurenone, a drug for uncontrolled hypertension with potential application in cardiovascular and kidney disease, from KBP...
Create an account or login to join the discussion